Strategies & Technologies Driving Drug Discovery to Market
Thermal Field Emission Analytical SEM
October 5, 2007 5:14 pm | Product Releases | CommentsJEOL’s JSM-7001F features a lens field emission gun that delivers more than 200 nA of beam current to the sample.
Image Acquisition
October 5, 2007 5:03 pm | Product Releases | CommentsLeica’s SD6000 Spinning Disk Confocal module is designed for observing differentiation processes, intracellular transport, cell division, and dynamics of the cytoskeleton over long periods of time.
High Resolution Imaging
October 5, 2007 4:44 pm | Product Releases | CommentsThe Nova NanoSEM 30 series from FEI is a field emission SEM series that features new low kV performance, high current, and high-resolution operation in low vacuum.
Scanning Electron Microscope
October 5, 2007 4:28 pm | Product Releases | CommentsCarl Zeiss SMT presents the newly designed EVO LS microscope series scanning electron microscope (SEM) built on the foundations laid by the EVO series.
FDA, Defense Department Share Data
October 5, 2007 4:23 pm | News | CommentsThe FDA and the Department of Defense (DoD) announced plans to share data and expertise related to the review and use of FDA-regulated drugs, biologics, and medical devices.
Schizophrenia Trial Initiated
October 5, 2007 4:19 pm | News | CommentsTargacept announced that its strategic collaborator AstraZeneca has initiated a Phase IIb clinical trial of AZD3480 (TC-1734) in cognitive deficits in schizophrenia.
Alternative Development Paths Sought
October 5, 2007 4:15 pm | News | CommentsGene Logic entered into a drug repositioning and development agreement with Merck Serono, a division of Merck KGaA of Germany, to seek alternative development paths for several Merck Serono drug candidates.
Metabolic Disorders Program Finalized
October 5, 2007 4:05 pm | News | CommentsBristol-Myers Squibb and Pfizer finalized an agreement for the worldwide collaboration to research, develop, and commercialize DGAT-1 inhibitors.Pfizer will be responsible for all research and early-stage development activities for the metabolic disorders program, and the companies will jointly conduct Phase 3 development and commercialization activities.
Separating the Good from the Bad in Pain Killers
October 5, 2007 3:59 pm | News | CommentsInvestigators at Washington University School of Medicine, St. Louis, Mo., succeeded in separating the good effects of opiate drugs from the unwanted side effects of those drugs.
Supportive Cells Generate New Nerve Cells
October 5, 2007 3:48 pm | News | CommentsResearchers have shown functional nerve cells can be generated from astroglia, a type of supportive cells in the brain by means of special regulator proteins.
Nanotoxicology Study Shows Promising Results
October 5, 2007 3:41 pm | News | CommentsA team from Oak Ridge National Laboratory’s (ORNL) Environmental Sciences Division reported no pulmonary toxicity issues for single-walled carbon nanohorns for drug delivery.
Shedding Light on Molecules in Living Cells
October 5, 2007 3:25 pm | News | CommentsClemson University chemists have developed a method to improve the longevity of fluorescent nanoparticles that may help researchers track the motion of a single molecule as it travels through a living cell.
Blade Servers
October 5, 2007 1:39 pm | Product Releases | CommentsSGI Altix ICE 8200 is the first in a new line of bladed servers purpose-built to handle true HPC applications and large scaleout workloads.
Peak Analysis Software
October 5, 2007 1:35 pm | Product Releases | CommentsADInstruments launched Peak Analysis chart software module for use with PowerLab data acquisition systems that speeds analysis of peaks in waveform data.
EP-NIR Analyzers
October 5, 2007 1:24 pm | Product Releases | CommentsAspectrics manufactures a complete line of Infrared and Near Infrared spectrometers for both at-line and on-line process related applications.
